News
Gilead to buy Kite for promising cancer therapies in $12 billion deal...
www.reuters.com
Gilead Sciences Inc agreed to buy Kite Pharma Inc in a nearly $12 billion deal on Monday, as it looks to replace flagging sales from hepatitis C drugs with...
Cancer treatment: Gilead to buy Kite for $11.9 billion in cancer drug...
economictimes.indiatimes.com
With Kite, Gilead will gain cancer therapies and experimental drugs in one of the most promising fields in oncology, in addition to its hepatitis C drug...
Coverage: Gilead to buy Kite Pharma for $11 billion - Talking Biz News
talkingbiznews.com
Coverage: Gilead to buy Kite Pharma for $11 billion. by Chris Roush · August 29, Screen Shot at PM Gilead Sciences Inc. has agreed ...
Gilead Sciences to buy Kite Pharma for $11.9B to expand cancer drug...
eu.usatoday.com
Gilead Sciences, a cancer-drug maker, agreed Monday to pay about $11.9 billion to buy Kite Pharma, a move to expand its product lineup in ...
sortiert nach Relevanz / Datum